Indirect Calorimetry in Patients at Risk of Malnutrition
Launched by UNIVERSITY OF LIEGE · Aug 1, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how much energy burn patients and survivors of intensive care unit (ICU) treatment need for their recovery. When patients have burns or have been critically ill, they can be at risk of not getting enough nutrients, which can affect their healing. The researchers want to measure the resting energy expenditure, which is the amount of energy your body uses while at rest, using a method called indirect calorimetry. This study hopes to provide better guidelines for nutrition in these patients.
To be eligible for this trial, participants must be adults aged 65 and older who either have minor burns treated in an outpatient clinic or are survivors who spent at least 7 days in the ICU before being discharged. However, those who need oxygen support, have chest drainage, are not French-speaking, or have confusion or cognitive disorders cannot participate. If you join the study, you can expect to undergo simple tests to measure your energy needs, which will help improve nutrition support for patients like you in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • minor burn treated in an outpatient setting
- • ICU survivor, who was discharged from ICU after a stay of at least 7 days
- Exclusion Criteria:
- • oxygen supply
- • chest drainage
- • not french speaking
- • confusion, coma
- • cognitive disorder
- • patient refusal
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials